Epic Corporation Stock Other OTC
Equities
US29428L2051
Blockchain & Cryptocurrency
End-of-day quote
Other stock markets
|
||
- USD | - |
2022 | Sanofi profit gain beats market view on bestseller drug Dupixent | RE |
2022 | Sanofi to float drug ingredients manufacturing business on May 6 | RE |
Sales 2008 | 22.12K 30.13K | Sales 2009 | 5.22K 7.11K | Capitalization | 563K 767K |
---|---|---|---|---|---|
Net income 2008 | - 0 | Net income 2009 | - 0 | EV / Sales 2008 | 33.3 x |
Net Debt 2008 | 399K 544K | Net Debt 2009 | 673K 917K | EV / Sales 2009 | 237 x |
P/E ratio 2008 |
-0.98
x | P/E ratio 2009 |
-1.34
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 97-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 97-09-30 |
1st Jan change | Capi. | |
---|---|---|
+29.91% | 55.48B | |
+81.58% | 10.93B | |
+8.95% | 1.14B | |
-40.95% | 575M | |
+72.70% | 538M | |
+171.17% | 445M | |
-51.76% | 336M | |
-.--% | 116M | |
-68.43% | 110M |